Drugs / Ammonul
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | AMMONUL | — | 2005-02-17 | fda.gov ↗ |
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT00977600 Comparator | Mar → Jul 2005 | — | Amgen | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ammonul | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00977600 ↗ |
| Route | Intravenous | “administered as an intravenous infusion over a 120-minute period” NCT00977600 ↗ |